BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17032900)

  • 21. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 2003 Australian Breast Health Survey: survey design and preliminary results.
    Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
    BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competing risks to breast cancer mortality.
    Rosenberg MA
    J Natl Cancer Inst Monogr; 2006; (36):15-9. PubMed ID: 17032889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience.
    Habbema JD; Schechter CB; Cronin KA; Clarke LD; Feuer EJ
    J Natl Cancer Inst Monogr; 2006; (36):122-6. PubMed ID: 17032902
    [No Abstract]   [Full Text] [Related]  

  • 26. Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach.
    Mahnken JD; Chan W; Freeman DH; Freeman JL
    Stat Methods Med Res; 2008 Dec; 17(6):643-63. PubMed ID: 18445697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
    Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
    J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Forecasting age-specific breast cancer mortality using functional data models.
    Erbas B; Hyndman RJ; Gertig DM
    Stat Med; 2007 Jan; 26(2):458-70. PubMed ID: 16217849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
    Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
    Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cancer registry and clinical data as predictors for breast cancer survival.
    Seppänen J; Heinävaara S; Holli K; Hakulinen T
    Cancer Causes Control; 2008 Dec; 19(10):1299-304. PubMed ID: 18752035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015.
    De Angelis R; Tavilla A; Verdecchia A; Scoppa S; Hachey M; Feuer EJ; Mariotto AB
    Cancer; 2009 May; 115(9):1954-66. PubMed ID: 19248047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in presentation of breast cancer in a community hospital.
    Palace FM; Magidson JG; Swayne LC
    N J Med; 1992 Feb; 89(2):134-6. PubMed ID: 1549263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of trends in incidence and mortality rates of breast cancer, incidence to mortality ratio and stage at diagnosis between Arab and Jewish women in Israel, 1979-2002.
    Tarabeia J; Baron-Epel O; Barchana M; Liphshitz I; Ifrah A; Fishler Y; Green MS
    Eur J Cancer Prev; 2007 Feb; 16(1):36-42. PubMed ID: 17220702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and validity of the Champion's Health Belief Model Scale among Lithuanian women.
    Zelviene A; Bogusevicius A
    Cancer Nurs; 2007; 30(3):E20-8. PubMed ID: 17510578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan.
    Hsieh HJ; Chen TH; Chang SH
    Stat Med; 2002 Nov; 21(22):3369-82. PubMed ID: 12407678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.